Abstract
Oral tolerance is the immunologic mechanism by which the mucosal immune system maintains unresponsiveness to the myriad of antigens in the mucosal environment which might otherwise induce untoward immune responses. Recent studies have shown that it is mediated by several distinct, yet interacting mechanisms including the generation of suppressive T cells producing antigen nonspecific cytokines and the induction of clonal deletion and/or anergy. In this review of oral tolerance, we discuss these mechanisms in detail and show how oral tolerance or lack therof may explain the occurrence of mucosal inflammation. In addition, we discuss how induction of oral tolerance can be used to treat autoimmune states.
Similar content being viewed by others
REFERENCES
Asherson GL, Zembala M, Perera MACC, Mayhew B, Thomas WR: Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents, and the role of suppressor cells in the Peye's patches, mesenteric lymph nodes and other lymphoid tissues. Cell Immunol 33:145–155, 1977
Tomasi TB: Oral tolerance. Transplantation 29:353–356, 1980
Kagnoff MF: Effects of antigen-feeding on intestinal and systemic immune responses. II. Suppression of delayed type hypersensitivity reactions. J Immunol 120:1509–1513, 1978
MacDonald TT: Immunosuppression caused by antigen feeding. II. Suppressor T cells mask Peyer's patches B cell priming to orally administered antigen. Eur J Immunol 13:138–142, 1983
Stokes CR, Newby TJ, Huntley JH, Patel D, Bourne FJ: The immune response of mice to bacterial antigens given by mouth. Immunology 38:497–502, 1979
Titus RG, Chiller JM: Orally induced tolerance: Definition at the cellular level. Int Arch Allergy Appl Immunol 65:323–338, 1981
Reese RT, Cebra JJ: Anti-dinitrophenyl antibody production in strain 13 guinea pigs fed or sensitized with dinitrochlorobenzene. J Immunol 114:863–871, 1975
Aizpura H, Russell-Jones G: Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding. J Exp Med 167:440–451, 1988
Elson CO, Ealding W: Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 132:2736–2741, 1984
Mowat AM, Thomas JJ, Parrott DMV: Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particular antigens in mice. Immunology 58:677–684, 1986
Strobel S, Ferguson A: Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell-mediated immune responses. Immunology 60:317–318, 1987
Zhang X, Brunner T, Carter L, Dutton, R, Rogers P, Bradley L, Sato T, Reed J, Green D, Swain S: Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 185:1837–1849, 1997
Ngan J, Kind LS: Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J Immunol 120:861–865, 1978
Sacklayen MG, Pesce AJ, Pollak VE, Michael JG: Kinetics of oral tolerance: Study of variables affecting tolerance induced by oral administration of antigen. Int Arch Allergy Appl Immunol 73:5–9, 1984
Challacombe SJ, Tomasi JB: Systemic tolerance and secretory immunity after oral immunization. J Exp Med 152:1459–1472, 1980
Fujihashi K, McGhee J, Yamamoto M, Hiroi T, Kiyono H: Role of lambda-delta T cells in the regulation of mucosal IgA response and oral tolerance. In Oral Tolerance, H. Weiner, L. Mayer (eds). New York: The New York Academy of Sciences, 1996, pp 55–63
Gesualdo L, Lamm ME, Emancipator S: Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. J Immunol 145:3684–3691, 1990
Richman L, Chiller J, Brown W, Hanson D, Vaz N: Enterically induced immunologic tolerance. I. Induction of suppressor T lymphocytes by intragastric administration of soluble proteins. J Immunol 121:2429–2434, 1978
Elson C, Edding W: Generalised systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 132:2736–2741, 1984
Kagnoff M, Cambell S: Functional characteristics of Peyer's patch lymphoid cells I. Induction of humoral antibody and cell-mediated allograft reactions. J Exp Med 139:398, 1974
Chase M, Battisto J: The duration of dermal sensitization following cellular transfer in guinea pigs. J Allergy 26:83, 1955
Thomas HC, Ryan CJ, Benjamin IS, Blumgart LH, MacSween RN: The immune response in cirrhotic rats. The induction of tolerance to orally administered protein antigens. Gastroenterology 71:114–117, 1976
Richman LK, Graeff AS, Strober W: Antigen presentation by macrophage-enriched cells from the mouse Peyer's patch. Cell Immunol 62:110–118, 1981
MacDonald T: Immunosuppression caused by antigen feeding. I. Evidence for the activation of a feedback suppressor pathway in the spleens of antigen-fed mice. Eur J Immunol 12:767–773, 1982
Nussenblatt R, Caspi R, Mahdi R, et al.: Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 144:1689–1696, 1990
Lider O, Santos L, Lee C, Higgins P, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol 142:748–752, 1989
Vistica B, Chanaud N, Felix N, et al.: CD8 T-cells are not essential for the induction of “low-dose” oral tolerance. Clin Immunol Immunopathol 78:196–202, 1996
Chen Y, Inobe J, Weiner H: Induction of oral tolerance to myelin basic protein in CD8-depleted mice: Both CD4+ and CD8+ cells mediate active suppression. J Immunol 155:910–916, 1995
Tada Y, Ho A, Koh D-R, Mak T: Collagen-induced arthritis in CD4-or CD8-deficient mice. CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol 156:4520–4526, 1996
Desvignes C, Bour H, Nicolas J, Kaiserlian D: Lack of oral tolerance but oral priming for contact sensitivity to dinitroflorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice. Eur J Immunol 26:1756–1761, 1996
Miller A, Lider O, Weiner H: Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 174:791–798, 1991
Miller A, Al-Sabbagh A, Santos L, Prabhu-Das M, Weiner H: Epitopes of myelin basic protein (MBP) that trigger TGF-β release following oral tolerization to MBP are different from encephalitogenic epitopes. J Immunol 151:7307–7315, 1993
Von Herrath M, Dyrberg T, Oldstone M: Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 98:1324–1331, 1996
Schluesener H, Lider O: Transforming growth factors beta 1 and beta 2: Cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function. J Neuroimmunol 24:249–258, 1989
Karpus W, Swanborg R: CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor β. J Immunol 146:1163–1169, 1991
Higgins P, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 140:440–445, 1988
Nagler Anderson C, Bober L, Robinson M, Siskind G, Thorbecke G: Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II antigen. Proc Natl Acad Sci USA 83:7443, 1986
Khoury SJ, Hancock WW, Weiner HL: Oral tolerence to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, prostaglandin E expression in the brain. J Exp Med 176:1355–1364, 1992
Miller A, Lider O, Roberts A, Sporn M, Weiner H: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor after antigen-specific triggering. Proc Natl Acad Sci USA 89:421–425, 1992
Powrie F, Correa-Oliveira R, Mauze S, Coffman R: Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179:589–600, 1994
Powrie F, Carlino J, Leach M, Mauze S, Coffman R: A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+ T cells. J Exp Med 183:2669–2674, 1996
Neurath M, Fuss I, Kelsall B, Stuber E, Strober W: Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182:1281–1290, 1995
Neurath M, Fuss I, Kelsall B, Presky D, Waegell W, Strober W: Experimental granulomatous colitis in mice is abrogated by induction of TGFβ-mediated oral tolerance. J Exp Med 183:2605–2616, 1996
Miller A, Zhang Z, Sobel R, Al-Sabbagh A, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization. J Neuroimmunol 46:73–82, 1993
Kearney E, Pape K, Loh D, Jenkins M: Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327–339, 1994
Perez V, Van Parijs L, Biuckians A, Zheng X, Strom T, Abbas A: Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411–417, 1997
Kulkarni A, Huh C, Becker D, et al.: Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770–774, 1993
Marth T, Strober W, Kelsall B: High dose oral tolerance in ovalbumin TCR transgenic mice: Systemic neutralization of interleukin-12 augments TGFβ secretion and T cell apoptosis. J Immunol 157:2348–2357, 1996
Marth T, Strober W, Seder R, Kelsall B: Regulation of transforming growth factor-β production by interleukin-12. Eur J Immunol 27:1213–1220, 1997
Seder R, Marth T, Sieve M, Strober W, Kelsall B: Factors involved in the differentiation of TGF-β-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own products.
Seder R, Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 12:635–673, 1994
Friedman A, Weiner H: Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91:6688–6692, 1994
Chen Y, Inobe J, Kuchroo V, Baron J, Chaneway C, Weiner H: Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 93:388–391, 1996
Chen Y, Kuchroo V, Inobe J, Hafler D, Weiner H: Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalitis. Science 265:1237–1240, 1994
Chen Y, Weiner H: Dose-dependent activation and deletion of antigen-specific T cells following oral tolerance. Ann NY Acad Sci 778:111–121, 1996
Inobe JI, Chen Y, Weiner HL: In vivo administration of IL-4 induces TGFβ producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann NY Acad Sci 778:390–392, 1996
Weiner H: Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today 18:335–343, 1997
Fukaura H, Kent S, Pietrusewic M, Khoury S, Weiner H, Hafler D: Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β-1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 98:70–77, 1996
Caspi R, Stiff L, Morawetz N, et al.: Cytokine-dependent modulation of oral tolerance in a murine model of autoimmune uveitis. Ann NY Acad Sci 778:315–337, 1996
Garside P, Steel E, Worthey A, et al.: Th2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol 154:3549–3555, 1995
Chen Y, Inobe J, Marks R, Gonella P, Kuchroo V, Weiner HL: Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177–180, 1995
Ehrhardt R, Ludviksson B, Gray B, Neurath M, Strober W: Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol 158:566–573, 1997
Ludviksson B, Gray B, Strober W, Ehrhardt R: Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes. J Immunol 158:104–111, 1997
Marinaro M, Staats H, Hiroi T, Jackson R, Coste M, Boyaka P, Okahashi N, Yamamoto M, Kiyono H, Bluethmann H, Fujihashi K, McGhee J: Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol 155:4621–4629, 1995
Ke Y, Pearce K, Lake J, Ziegler H, Kapp J: Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol 158:3610–3618, 1997
Ke J, Kapp J: Oral Antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells. J Immunol 156:916–921, 1996
Mengel J, Cardillo F, Aroeira L, Williams O, Russo M, Vaz N: Anti-gamma delta T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol Lett 48:97–102, 1995
Wildner G, Hunig T, Thurau S: Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis. Eur J Immunol 26:2140–2148, 1996
Harrison L, Dempsey-Collier M, Kramer D, Takahashi K: Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med 184:2167–2174, 1996
McMenamin C, Pimm C, McKersey M, Holt P: Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science 265:1869–1871, 1994
McMenamin C, McKersey M, Kuhnlein P, Hunig T, Holt P: Gamma delta T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J Immunol 154:4390–4394, 1995
Blumberg R, Balk S: Intraepithelial lymphocytes and their recognition of non-classical MHC molecules. Int Rev Immunol 11:15–30, 1994
Blumberg R, Terhorst C, Bleicher P, et al.: Expression of a nonpolymorphic MHC class I-like molecule CD1d, by human intestinal epithelial cells. J Immunol 147:2518–2524, 1991
Bruce MG, Ferguson A: Oral tolerance to ovalbumin in mice: Studies of chemically modified and of “biologically filtered” antigen. Immunology 57:627–630, 1986
Bruce M, Ferguson A: The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice. Immunology 159, 1986
Strobel S, Mowat A, Drummond H, Pickering M, Ferguson A: Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide sensitive cells by gut processed antigen. Immunology 49:451–456, 1983
Peng H, Turner M, Ferguson A: The generation of a tolerogen after the ingestion of ovalbumin is time dependent and unrelated to the serum level of immunoreactive protein. Clin Exp Immunol 81:510–515, 1990
Lamont A, Bruce M, Watret K, Ferguson A: Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization. Immunology 64:135–140, 1988
Kay R, Ferguson A: The immunological consequences of feeding cholera toxin. II. Mechanisms responsible for the induction of oral tolerance for DTH. Immunology 66:416–421, 1989
Kay R, Ferguson A: The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity. Immunology 66:410–415, 1989
Whitacre C, Gienapp I, Orosz C, Bitar D: Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 147:2155–2163, 1991
Gregerson D, Obritsch W, Donoso L: Oral tolerance in experimental autoimmune uveoretinitis: Distinct mechanisms of resistance are induced by low dose versus high dose feeding protocols. J Immunol 151:5751–5761, 1993
Van Houten N, Blake S: Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J Immunol 157:1337–1341, 1996
Schwartz R: Immunological tolerance. In Fundamental Immunology, WE Paul (ed). New York: Raven Press, 1993, pp 677–731
Lamont AG, Mowat A. Mcl., Browning MJ, Parott DMV: Genetic control of oral tolerance to ovalbumin in mice. Immunology 63:737–739, 1988
Mowat A, Lamont A, Bruce M: A genetically determined lack of oral tolerance to ovalbumin is due to failure of the immune system to respond to intestinally derived tolerogen. Eur J Immunol 17:1673–1676, 1987
Mowat A: The regulation of immune responses to dietary protein antigens. Immunol Today 8:93–98, 1987
Brown D, Moskowitz N, Killeen N, Reiner S: A role for CD4 in peripheral T cell differentiation. J Exp Med 186:101–107, 1997
Kagnoff M: Immunology and inflammation of the gastrointestinal tract. In Gastrointestinal Diseases, MH Sleisenger, JS Fordtran (eds). 1993, pp 45–86
Troncone R, Ferguson A: In mice, gluten in maternal diet primes systemic immune responses to gliaden in offspring. Immunology 64:533–537, 1988
Kiyono H, McGhee J, Wannemuehler M, Michalek S: Lack of oral tolerance in C3H/HeJ mice. J Exp Med 155:605–610, 1982
Michalek S, Kiyono H, Wannemuehler M, Mosteller L, McGhee JR: Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J Immunol 128:1992–1998, 1982
Khoury S, Lider O, Al-Sabbagh A, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell Immunol 131:302–310, 1990
Strobel S, Ferguson A: Modulation of intestinal and systemic immune responses to a fed protein antigen, in mice. Gut 27:829–837, 1986
Mowat AM, Parrott DMV: Immunological responses to fed protein antigens in mice. IV. Effects of stimulating the reticuloendothelial system on oral tolerance and intestinal immunity to ovalbumin. Immunology 50:547–554, 1983
Zhang Z, Michael JG: Orally inducible immune responsiveness is abrogated by IFN-γ treatment. J Immunol 144:4163–4165, 1990
Kweon H, Fujihashi K, Yamamoto M, VanCott JL, McGhee JR, Kiyono H: Mucosally induced tolerance in IL-4-/-but not IFN gamma-/-mice. FASEB J 10:A1028, 1996
Kjerrulf M, Grdic D, Lycke N: Impaired mucosal IgA responses by intact oral tolerance in IFN-lambda receptor deficient mice. FASEB J 10:A1418, 1996
Weiner H: Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med 48:341–351, 1997
Ludviksson BR, Ehrhardt RO, Strober W: TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. J Immunol 159:3622–3628, 1997
Hornquist E, Lycke N: Cholera toxin increases T lymphocyte responses to unrelated antigens. Adv Exp Med Biol 1995:1507–1512, 1995
Marinaro M, Boyaka P, Finkelman F, Kiyono H, Jackson R, Jirillo E, McGhee J: Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med 185:415–427, 1997
Takahashi I, Marinaro M, Kiyono H, et al.: Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis 173:627–635, 1996
Sun J, Rask C, Olsson T, Holmgren J, Czerkinsky C: Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci USA 93:7196–7201, 1996
Mowat A: Depletion of suppressor T cells by 2′-deoxyguanosine abrogates tolerance in mice fed ovalbumin and permits the induction of intestinal delayed-type hypersensitivity. Immunology 58:179–184, 1986
Nelson P, Akselband Y, Dearborn S, et al.: Effect of oral beta interon on subsequent immune responsiveness. In Oral Tolerance: Mechanisms and Applications, HL Weiner, LF Mayer (eds). New York: The New York Academy of Sciences, 1996, pp 145–155
Elson C, Tomasi M, Dertzbaugh M, Thaggard G, Hunter R, Weaver C: Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance. In Oral Tolerance: Mechanisms and Applications, H Weiner, L Mayer (eds). New York: The New York Academy of Sciences, 1996, Vol 778, pp 156–162
Karpus W, Lukacs N: The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1. In Tolerance: Mechanisms and Applications, H Weiner, L Mayer (eds). New York: The New York Academy of Sciences, 1996, pp 133–144
Strober W, Neurath MF: Immunological diseases of the gastrointestinal tract. In Clinical Immunology, RR Rich (eds). St. Louis: Mosby, 1995, pp 1401–1428
Sollid LM, Markussen G, Ek J: Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 169:345, 1989
Ferguson A (ed): In Models of Immunologically-Driven Small Intestinal Damage, MN Marsh (ed). Chichester: John Wiley and Sons, 1987, pp 225–252
Nilsen EM, Lundin Ke, Krajci P, Scott H, Sollid LM, Brandtzaeg P: Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37:766–776, 1995
Strokes CR, Miller BG, Bourne FJ: Animal models of food sensitivity. In Food Alergy and Intolerance, J Brostoff, SJ Challacombe (eds). Eastbourne: Saunders, 1987, pp 286–300
Barratt MEJ, Powell JR, Allen WD, Porter P (eds): Immunopathology of intestinal disorders in farm animals. In Immunopathology of Intestinal Disorders in Farm Animals, MN Marsh (ed). Chichester: John Wiley and Sons, 1987, pp 253–258
Podolsky DK: Inflammatory bowel disease. N Engl J Med 325:928–937, 1991
Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiochhi C, Strober W: Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J Immunol 157:1261–1270, 1996
Van Dulleman HM, Van Deventer SJ, Hommes DW, Biji HA, Jansen J, Tytgat GN: Treatment of Crohn's disease with antitumor necrosis factor chimeric monoclonal antibody (CA2). Gastroenterology 109:129–135, 1995
Strober W, Ehrhardt RO. Cronic Intestinal inflammation: An unexpected outcome of cytokine or T cell receptor mutant mice. Cell 75:203–205, 1993
Takahashi I, Kiyono H, Hamada S: CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology 112:1876–1886, 1997
Neurath MF, Pettersson S, Meyer zum Buschenfelde K-H, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kB abrogates established experimental colitis in mice. Nature Med 2:998–1003, 1996
Neurath M, Fuss I, Pasparakis M, Alexopoulos L, Haralambous S, Meyer zum Buschenfeld K-H, Strober W, Kollias G: Predominant pathogenic role of tumor necrosis factor alpha in experimental colitis in mice. Eur J Immunol 27:27–34, 1997
Sartor BD, Roth HC, Sellon RK: Microbial factors in chronic intestinal inflammation. Curr Opin Gastroenterol 12:327–333, 1996
Meyer AL, Benson JM, Gienapp IE, Cox KI, Whitacre CC: Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J Immunol 157:4230–4238, 1996
Brod S, Al-Sabbagh R, Hafler D, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Supression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Ann Neurol 29:615–622, 1991
Zhang ZJA, Davidson L, Eisenbarth G, Weiner HL: Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 88:10252–10256, 1991
Tian J, Atkinson MA, Clare-Salzler M, Forsthuber T, Lehmann PV, Kaufman DL: Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183:1561–1567, 1996
Thompson HSG Staines NA: Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 64:581–586, 1986
Peterson KE, Braley-Mullen H: Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin. Cell Immunol 166:123–130, 1995
Sayegh MH, Zhang ZJA, Hancock WW, Kwok CA, Carpenter CB, Weiner HL: Down-regulation of the immune response to histocompatibility antigen and prevention of sensitization by skin allografts by orally administered autoantigen. Transplantation 53:163–166, 1992
Wang ZY, Huang, J, Olsson T, He B, Link H: B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. J Neurol Sci 128:167–174, 1995
Husby S, Mestecky J, Moldoveanu Z, Holland S, Elson CO: Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol 152:4663–4670, 1994
Weiner HL: Trearment of autoimmune diseases by oral tolerance to autoantigens. Autoimmunity 15(Suppl):6–7, 1993
Sieper J, Kary S, Sörensen H, Alten R, Eggens U, Hüge W, Hiepe F, Kühne A, Listing J, Ulbrich N, Braun J, Zink A, Mitchison NA: Oral type II collagen treatment in early rheumatoid arthritis. Arthr Rheum 39:41–51, 1996
Nussenblatt R, Whitcup S, de Smet M, Caspi R, Kozhich A, Weiner H, Vistica B, Gery I: Intraocular inflammatory disease (uveitis) and the use of oral tolerance: A status report. Ann NY Acad Sci 778:325–327, 1996
Nussenblatt RB, Gery I, Weiner HL, Ferris FL, Shiloach J, Remaley N, Perry C, Caspi RR, Hafler DA, Foster CS, Whitcup SM. Treatment of uveitis by oral administration of retinal antigens: Results of a phase I/II randomized masked trial. Am J Ophthalmol 123:583–592, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strober, W., Kelsall, B. & Marth, T. Oral Tolerance. J Clin Immunol 18, 1–30 (1998). https://doi.org/10.1023/A:1023222003039
Issue Date:
DOI: https://doi.org/10.1023/A:1023222003039